中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2013年
8期
1150-1153,后插2
,共5页
窦文广%吴清武%陈杰%朱止平%岳军艳
竇文廣%吳清武%陳傑%硃止平%嶽軍豔
두문엄%오청무%진걸%주지평%악군염
癌,肝细胞%体层摄影术,X线计算机
癌,肝細胞%體層攝影術,X線計算機
암,간세포%체층섭영술,X선계산궤
Carcinoma,hepatocellular%Tomography,X-ray computed
目的 在肝癌高发人群中对CT动脉增强期所发现的小结节(5~10 mm) (SAENs)进行随访观察,以确定肝细胞癌(HCC)发生率和危险因素.方法 研究对象包括112例患者(男∶女=100∶12;年龄36 ~ 92岁),通过最初的CT检查中共发现175个SAENs.在随访期间(1.4 ~41.8个月,平均35.7个月)对CT检查结果进行观察分析,以最终阐明结节为肝癌的危险因素和比例.结果 随访期间的175结节中,有101 (57.7%)消失,34个(19.4%)持续存在,40个(22.9%)结节最终确诊为肝癌(33例患者).其中患者有肝癌治疗史(P =0.005,风险比=7.429),较大尺寸的SAEN(P=0.003,风险比=1.630),肝内有同时发现的HCC(P=0.021,风险比=3.777)和缺乏共存的典型的动静脉分流(P=0.003,风险比=4.459)是在CT影响学上肝内结节可能为HCC的风险因素.结论 在肝癌高发人群中经常能发现SAEN,其中有22.9%的硬结节有可能为肝癌,特别是当有下列因素存在包括合并有肝癌病史,有同时存在的肝癌、结节较大以及没有发现共存的典型动静脉分流时,肝癌发生率会明显升高.
目的 在肝癌高髮人群中對CT動脈增彊期所髮現的小結節(5~10 mm) (SAENs)進行隨訪觀察,以確定肝細胞癌(HCC)髮生率和危險因素.方法 研究對象包括112例患者(男∶女=100∶12;年齡36 ~ 92歲),通過最初的CT檢查中共髮現175箇SAENs.在隨訪期間(1.4 ~41.8箇月,平均35.7箇月)對CT檢查結果進行觀察分析,以最終闡明結節為肝癌的危險因素和比例.結果 隨訪期間的175結節中,有101 (57.7%)消失,34箇(19.4%)持續存在,40箇(22.9%)結節最終確診為肝癌(33例患者).其中患者有肝癌治療史(P =0.005,風險比=7.429),較大呎吋的SAEN(P=0.003,風險比=1.630),肝內有同時髮現的HCC(P=0.021,風險比=3.777)和缺乏共存的典型的動靜脈分流(P=0.003,風險比=4.459)是在CT影響學上肝內結節可能為HCC的風險因素.結論 在肝癌高髮人群中經常能髮現SAEN,其中有22.9%的硬結節有可能為肝癌,特彆是噹有下列因素存在包括閤併有肝癌病史,有同時存在的肝癌、結節較大以及沒有髮現共存的典型動靜脈分流時,肝癌髮生率會明顯升高.
목적 재간암고발인군중대CT동맥증강기소발현적소결절(5~10 mm) (SAENs)진행수방관찰,이학정간세포암(HCC)발생솔화위험인소.방법 연구대상포괄112례환자(남∶녀=100∶12;년령36 ~ 92세),통과최초적CT검사중공발현175개SAENs.재수방기간(1.4 ~41.8개월,평균35.7개월)대CT검사결과진행관찰분석,이최종천명결절위간암적위험인소화비례.결과 수방기간적175결절중,유101 (57.7%)소실,34개(19.4%)지속존재,40개(22.9%)결절최종학진위간암(33례환자).기중환자유간암치료사(P =0.005,풍험비=7.429),교대척촌적SAEN(P=0.003,풍험비=1.630),간내유동시발현적HCC(P=0.021,풍험비=3.777)화결핍공존적전형적동정맥분류(P=0.003,풍험비=4.459)시재CT영향학상간내결절가능위HCC적풍험인소.결론 재간암고발인군중경상능발현SAEN,기중유22.9%적경결절유가능위간암,특별시당유하렬인소존재포괄합병유간암병사,유동시존재적간암、결절교대이급몰유발현공존적전형동정맥분류시,간암발생솔회명현승고.
Objective To evaluate the outcomes of small (5 ~ 10mm),arterially enhancing nodules (SAENs)shown exclusively at the hepatic arterial phase of CT in a hepatocellular carcinoma(HCC) surveillance population and to determine risk factors for developing HCC.Methods The study population included 112 patients (maleifemale =100 ∶ 12 ; aged 36 ~ 92 years) with 1 7 5 SAENs who were at risk of HCC.We evaluated serial changes during follow-up(1.4 ~41.8 months,mean 35.7 months) and analysed the initial CT findings of SAENs and the accompanying lesions to elucidate the risk factors for HCC development.Results Of 175 SAENs,101 (57.7%) disappeared and 34(19.4%) persisted.Forty SAENs(22.9%) became HCC in 33 patients(29.5%).Presence of HCC treatment history(P =0.005,risk ratio =7.429),a larger size of SAEN(P =0.003,risk ratio =1.630),presence of coexistent HCC(P =0.021,risk ratio =3.777) and absence of coexistent typical arterioportal shunts (P =0.003,risk ratio =4.459) turned out to be independently significant risk factors for future development of HCC.Conclusion SAENs are frequently seen in an HCC surveillance population and have a 22.9% probability of becoming HCC on a per-lesion basis.Risk increased particularly when the lesion is associated with a previous or concurrent HCC,a large size or found without a coexistent typical arterioportal shunt.